To conclude, the key findings in this study elicited that MSCs‐EVs could carry miR‐378a‐3p to inhibit the transcription factor GATA2, which can downregulate the expression of AQP4 and block PPAR‐α signalling pathway, thus inhibiting the occurrence of IBD (Figure 7). This evidence concerns the gene GATA2 and inflammatory bowel disease.